Evidence map›Paper›PMID 30479862›Full record

ArticleDermatology practical & conceptual2018

Clinicopathologically problematic melanocytic tumors: a case-based review.

Zoe Apalla, Christina Nikolaidou, Aimilios Lallas, Elena Sotiriou, Elizabeth Lazaridou, Ioannis Venizelos, Mattheos Bobos, Efstratios Vakirlis, Demetrios Ioannides, Gerardo Ferrara

Open access · diamondAbstract read
PubMed Full text at PMC Publisher
In one paragraph

Article in Dermatology practical & conceptual, 2018. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.

0numbers the graph read from it
0cells of the map it votes in
1citing papers in PubMed
0.4field-weighted citation impact, top 33% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

1 citing paper in PubMed, 7 citations in OpenAlex.

  1. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

10 authors at 3 institutions in 2 countries.

Zoe ApallaFirst Dermatology Department, Aristotle University of Thessaloniki, Greece.
Christina NikolaidouFirst Dermatology Department, Aristotle University of Thessaloniki, Greece.
Aimilios LallasFirst Dermatology Department, Aristotle University of Thessaloniki, Greece.
Elena SotiriouFirst Dermatology Department, Aristotle University of Thessaloniki, Greece.
Elizabeth LazaridouSecond Dermatology Department, Aristotle University of Thessaloniki, Greece.
Ioannis VenizelosAnatomic Pathology Unit, Hippokration Hospital, Thessaloniki, Greece.
Mattheos BobosMicrodiagnostics Pathology Laboratory, Thessaloniki, Greece.
Efstratios VakirlisFirst Dermatology Department, Aristotle University of Thessaloniki, Greece.
Demetrios IoannidesFirst Dermatology Department, Aristotle University of Thessaloniki, Greece.
Gerardo FerraraAnatomic Pathology Unit, Hospital of Macerata, Italy.
Aristotle University of Thessaloniki · GRHippocration General Hospital · GRUniversity of Macerata · IT

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

backgroundIn spite of recent advances in the histopathological and molecular diagnosis of melanocytic neoplasms, a certain proportion of these lesions remain a daunting challenge for both the clinician and the pathologist.

objectivesTo emphasize the importance of close collaboration between clinicians and pathologists in case of problematic melanocytic lesions. PATIENTS: We report and discuss 5 problematic scenarios of melanocytic lesions, including tumoral melanosis, nevoid melanoma, lentiginous melanoma, spitzoid melanoma and BAPoma that may pose diagnostic difficulties in our practice.

conclusionsClinico-dermoscopic-pathological correlation, with incorporation of all the available data, in problematic melanocytic skin neoplasms is of paramount importance for accurate diagnosis.

Indexed as

dermoscopymelanomanevusskin cancerspitzoid

Identifiers

PMID30479862
PMCPMC6246059
OpenAlexW2919318575

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.